DAS
BTAI icon

Dynamic Advisor Solutions’s BioXcel Therapeutics BTAI Stock Holding History

Dynamic Advisor Solutions’s Portfolio BTAI Stock Details BTAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-625
Closed -$187K – 811
2023
Q1 		$187K Buy
+625
New +$267K 0.01% 703

Other funds holding BTAI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $9.43B AUM 69.06% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Dynamic Advisor Solutions's BTAI Position: Q2 2023 in Review

Dynamic Advisor Solutions sold out of BioXcel Therapeutics (BTAI) in Q2 2023, closing a stake of 625 shares — an estimated $187K sold.

Dynamic Advisor Solutions first reported a position in BTAI in Q1 2023 and held it in 1 quarter. The position peaked at $187K in Q1 2023. 88 funds tracked by Wall St. Rank hold BTAI as of Q2 2023.

  • Dynamic Advisor Solutions reported no remaining BioXcel Therapeutics position as of Q2 2023 after selling out during the quarter.
  • Dynamic Advisor Solutions sold 625 BioXcel Therapeutics shares in Q2 2023, an estimated $187K.
  • Dynamic Advisor Solutions first reported a position in BioXcel Therapeutics in Q1 2023 and held it in 1 quarter.
  • Dynamic Advisor Solutions's BioXcel Therapeutics position peaked at $187K in Q1 2023.
  • 88 funds tracked by Wall St. Rank held BioXcel Therapeutics as of Q2 2023.

Based on Dynamic Advisor Solutions's 13F filing for Q2 2023, filed 3 Aug 2023.